Adipokines and lipid profile changes in nonalcoholic fatty liver diseases patients

Abstract

Abnormal secretion of adipokines may play a key role in the development of metabolic syndrome, including non-alcoholic fatty liver disease (NAFLD) and progression of nonalcoholic steatohepatitis (NASH). Excessive visceral adipose tissue was identified as one of the main causes leading to the development of NAFLD.

Description

Citation

Zakharenkova A. V. Adipokines and lipid profile changes in nonalcoholic fatty liver diseases patients / A. V. Zakharenkova, K. A. Lapshyna, A. D. Bashkirova // Science and Life : Proceedings of articles the international scientific conference, Czech Republic, Karlovy Vary - Ukraine, Kyiv, 16–17 November 2017 [Electronic resource] / Editors: I. P. Klimov, I. V. Ignatko, V. B. Mantusov. – Karlovy Vary : Skleněný Můstek, 2017. – № 79. – P. 57–59.

Endorsement

Review

Supplemented By

Referenced By